Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP904810.RAD9m2ag77qbwd5eBzHRjccpKfnj67klw_2p-LQ_vpGNY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP904810.RAD9m2ag77qbwd5eBzHRjccpKfnj67klw_2p-LQ_vpGNY130_assertion type Assertion NP904810.RAD9m2ag77qbwd5eBzHRjccpKfnj67klw_2p-LQ_vpGNY130_head.
- NP904810.RAD9m2ag77qbwd5eBzHRjccpKfnj67klw_2p-LQ_vpGNY130_assertion wasGeneratedBy ECO_0000203 NP904810.RAD9m2ag77qbwd5eBzHRjccpKfnj67klw_2p-LQ_vpGNY130_provenance.
- NP904810.RAD9m2ag77qbwd5eBzHRjccpKfnj67klw_2p-LQ_vpGNY130_assertion wasDerivedFrom befree-2016 NP904810.RAD9m2ag77qbwd5eBzHRjccpKfnj67klw_2p-LQ_vpGNY130_provenance.
- NP904810.RAD9m2ag77qbwd5eBzHRjccpKfnj67klw_2p-LQ_vpGNY130_assertion SIO_000772 21703428 NP904810.RAD9m2ag77qbwd5eBzHRjccpKfnj67klw_2p-LQ_vpGNY130_provenance.
- NP904810.RAD9m2ag77qbwd5eBzHRjccpKfnj67klw_2p-LQ_vpGNY130_assertion evidence source_evidence_literature NP904810.RAD9m2ag77qbwd5eBzHRjccpKfnj67klw_2p-LQ_vpGNY130_provenance.
- NP904810.RAD9m2ag77qbwd5eBzHRjccpKfnj67klw_2p-LQ_vpGNY130_assertion description "[Comparable in efficacy with Bevacizumab, monotherapy with the PAR1 i3 loop pepducin P1pal-7 provided significant 75% inhibition of lung tumor growth in nude mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904810.RAD9m2ag77qbwd5eBzHRjccpKfnj67klw_2p-LQ_vpGNY130_provenance.